Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

DCGI asks SII to revise protocol for phase 2, 3 trials of Oxford COVID-19 vaccine

expresspharmaJuly 30, 2020

Tag: DCGI , COVID-19 vaccine , SII

PharmaSources Customer Service